FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981831261> ?p ?o ?g. }

• W2981831261 abstract "Abstract Purpose An association between antibody deficiency and clozapine use in individuals with Schizophrenia has recently been reported. We hypothesized that if clozapine-associated hypogammaglobulinaemia was clinically relevant this would manifest in referral patterns. Methods Retrospective case note review of patients referred and assessed by Immunology Centre for Wales (ICW) between January 2005 and July 2018 with extraction of clinical and immunologic features for individuals with diagnosis of schizophrenia-like illness. Results 1791 adult patients were assessed at ICW during this period; 23 patients had a psychiatric diagnosis of schizophrenia or schizo-affective disorder. Principal indications for referral were findings of low calculated globulin and immunoglobulins. Clozapine was the single most commonly prescribed antipsychotic (17/23), disproportionately increased relative to reported use in the general schizophrenia population (OR 6.48, 95% CI: 1.79 to 23.5). Clozapine therapy was noted in 6/7 (86%) of patients subsequently requiring immunoglobulin replacement therapy (IgRT). Marked reduction of class-switched memory B-cells (CSMB) and plasmablasts were observed in clozapine-treated individuals relative to healthy age-matched controls. Clozapine duration is associated with CSMB decline. One patient discontinued clozapine, with gradual recovery of IgG levels without use of IgRT. Conclusion Our findings are consistent with enrichment of clozapine-treatment within schizophrenic individuals referred for ICW assessment over the last 13 years. These individuals displayed clinical patterns closely resembling the primary immunodeficiency CVID, however appears reversible upon drug cessation. This has diagnostic, monitoring and treatment implications for psychiatry and immunology teams and directs prospective studies to address causality and the wider implications for this patient group." @default.
• W2981831261 created "2019-11-01" @default.
• W2981831261 creator A5002040929 @default.
• W2981831261 creator A5003773811 @default.
• W2981831261 creator A5004902335 @default.
• W2981831261 creator A5005453736 @default.
• W2981831261 creator A5005656847 @default.
• W2981831261 creator A5006462774 @default.
• W2981831261 creator A5025771813 @default.
• W2981831261 creator A5039496736 @default.
• W2981831261 creator A5044864879 @default.
• W2981831261 creator A5054102340 @default.
• W2981831261 creator A5055177146 @default.
• W2981831261 creator A5070141499 @default.
• W2981831261 creator A5077075313 @default.
• W2981831261 creator A5087292243 @default.
• W2981831261 date "2019-10-02" @default.
• W2981831261 modified "2023-09-27" @default.
• W2981831261 title "Clinical and laboratory characteristics of clozapine treated schizophrenia patients referred to a national immunodeficiency clinic reveals a B-cell signature resembling CVID" @default.
• W2981831261 cites W1968870951 @default.
• W2981831261 cites W1986562944 @default.
• W2981831261 cites W1992126368 @default.
• W2981831261 cites W1996858839 @default.
• W2981831261 cites W2001157702 @default.
• W2981831261 cites W2008840144 @default.
• W2981831261 cites W2044910154 @default.
• W2981831261 cites W2050218130 @default.
• W2981831261 cites W2065293336 @default.
• W2981831261 cites W2075980253 @default.
• W2981831261 cites W2101126028 @default.
• W2981831261 cites W2102094268 @default.
• W2981831261 cites W2102617539 @default.
• W2981831261 cites W2105224023 @default.
• W2981831261 cites W2113758182 @default.
• W2981831261 cites W2118850644 @default.
• W2981831261 cites W2119333273 @default.
• W2981831261 cites W2120839494 @default.
• W2981831261 cites W2127523802 @default.
• W2981831261 cites W2128600935 @default.
• W2981831261 cites W2138320537 @default.
• W2981831261 cites W2138790262 @default.
• W2981831261 cites W2235970093 @default.
• W2981831261 cites W2297268963 @default.
• W2981831261 cites W2408755897 @default.
• W2981831261 cites W2417262312 @default.
• W2981831261 cites W2549349499 @default.
• W2981831261 cites W2562948953 @default.
• W2981831261 cites W2568509854 @default.
• W2981831261 cites W2620716611 @default.
• W2981831261 cites W2765340093 @default.
• W2981831261 cites W2804083145 @default.
• W2981831261 cites W2888687366 @default.
• W2981831261 cites W2907153405 @default.
• W2981831261 cites W2913784281 @default.
• W2981831261 cites W2976667785 @default.
• W2981831261 cites W3216674547 @default.
• W2981831261 cites W4211145950 @default.
• W2981831261 doi "https://doi.org/10.1101/19007815" @default.
• W2981831261 hasPublicationYear "2019" @default.
• W2981831261 type Work @default.
• W2981831261 sameAs 2981831261 @default.
• W2981831261 citedByCount "0" @default.
• W2981831261 crossrefType "posted-content" @default.
• W2981831261 hasAuthorship W2981831261A5002040929 @default.
• W2981831261 hasAuthorship W2981831261A5003773811 @default.
• W2981831261 hasAuthorship W2981831261A5004902335 @default.
• W2981831261 hasAuthorship W2981831261A5005453736 @default.
• W2981831261 hasAuthorship W2981831261A5005656847 @default.
• W2981831261 hasAuthorship W2981831261A5006462774 @default.
• W2981831261 hasAuthorship W2981831261A5025771813 @default.
• W2981831261 hasAuthorship W2981831261A5039496736 @default.
• W2981831261 hasAuthorship W2981831261A5044864879 @default.
• W2981831261 hasAuthorship W2981831261A5054102340 @default.
• W2981831261 hasAuthorship W2981831261A5055177146 @default.
• W2981831261 hasAuthorship W2981831261A5070141499 @default.
• W2981831261 hasAuthorship W2981831261A5077075313 @default.
• W2981831261 hasAuthorship W2981831261A5087292243 @default.
• W2981831261 hasBestOaLocation W29818312611 @default.
• W2981831261 hasConcept C118552586 @default.
• W2981831261 hasConcept C126322002 @default.
• W2981831261 hasConcept C159654299 @default.
• W2981831261 hasConcept C187212893 @default.
• W2981831261 hasConcept C203014093 @default.
• W2981831261 hasConcept C2776412080 @default.
• W2981831261 hasConcept C2776433325 @default.
• W2981831261 hasConcept C2780494398 @default.
• W2981831261 hasConcept C2780864610 @default.
• W2981831261 hasConcept C2908647359 @default.
• W2981831261 hasConcept C71924100 @default.
• W2981831261 hasConcept C99454951 @default.
• W2981831261 hasConceptScore W2981831261C118552586 @default.
• W2981831261 hasConceptScore W2981831261C126322002 @default.
• W2981831261 hasConceptScore W2981831261C159654299 @default.
• W2981831261 hasConceptScore W2981831261C187212893 @default.
• W2981831261 hasConceptScore W2981831261C203014093 @default.
• W2981831261 hasConceptScore W2981831261C2776412080 @default.
• W2981831261 hasConceptScore W2981831261C2776433325 @default.
• W2981831261 hasConceptScore W2981831261C2780494398 @default.
• W2981831261 hasConceptScore W2981831261C2780864610 @default.
• W2981831261 hasConceptScore W2981831261C2908647359 @default.

• next